Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
10,694
datasets available to search
ShareScore release 0.9.0
Dataset results
10,694 results for “carcinoma,”
Pembrolizumab (MK-3475) as First-line Therapy for Advanced Merkel Cell Carcinoma (MK-3475-913)
ClinicalTrials.gov study NCT03783078. IPD Sharing: YES. Countries: 8. Publications: 1.
A Study of Belzutifan (MK-6482) Versus Everolimus in Participants With Advanced Renal Cell Carcinoma (MK-6482-005)
ClinicalTrials.gov study NCT04195750. IPD Sharing: YES. Countries: 23. Publications: 2.
Temsirolimus (Torisel®) and Erlotinib (Tarceva®) in Platinum-Refractory/Ineligible, Advanced, Squamous Cell Carcinoma
ClinicalTrials.gov study NCT01009203. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Lenvatinib/Everolimus or Lenvatinib/Pembrolizumab Versus Sunitinib Alone as Treatment of Advanced Renal Cell Carcinoma
ClinicalTrials.gov study NCT02811861. IPD Sharing: Not stated. Countries: 20. Publications: 12.
Testing Afatinib in Combination With Pembrolizumab in Patients With Squamous Cell Carcinoma of the Lung
ClinicalTrials.gov study NCT03157089. IPD Sharing: UNDECIDED. Countries: 5. Publications: 2.
TRC105 in Adults With Advanced/Metastatic Urothelial Carcinoma
ClinicalTrials.gov study NCT01328574. IPD Sharing: NO. Countries: 1. Publications: 1.
RAD001 in Advanced Hepatocellular Carcinoma
ClinicalTrials.gov study NCT00516165. IPD Sharing: NO. Countries: 1. Publications: 1.
Study of TAK-228 In Patients With Previously Treated Metastatic Renal Cell Carcinoma
ClinicalTrials.gov study NCT03097328. IPD Sharing: NO. Countries: 1. Publications: 1.
Paclitaxel/Carboplatin Plus Bevacizumab/Erlotinib in the First Line Treatment of Carcinoma of Unknown Primary Site
ClinicalTrials.gov study NCT00360360. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Reconstruction of Cervical Lymphatic System During Head and Neck Squamous Cell Carcinoma Surgery
ClinicalTrials.gov study NCT06815705. IPD Sharing: YES. Countries: 1. Publications: 13.
Next Generation Sequencing-Based Stratification of Front Line Treatment of HighGrade Neuroendocrine Carcinoma
ClinicalTrials.gov study NCT04452292. IPD Sharing: NO. Countries: 1. Publications: 1.
Rapamycin Therapy in Head and Neck Squamous Cell Carcinoma
ClinicalTrials.gov study NCT01195922. IPD Sharing: NO. Countries: 1. Publications: 3.
Chemotherapy After Prostatectomy (CAP) For High Risk Prostate Carcinoma
ClinicalTrials.gov study NCT00132301. IPD Sharing: UNDECIDED. Countries: 2. Publications: 1.
Study of Atezolizumab + Bevacizumab in Patients With Advanced Non-Clear Cell Renal Cell Carcinoma
ClinicalTrials.gov study NCT02724878. IPD Sharing: YES. Countries: 1. Publications: 2.
Pembrolizumab in Patients With Poor-Prognosis Carcinoma of Unknown Primary Site (CUP)
ClinicalTrials.gov study NCT03391973. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Preoperative Chemoradiotherapy and MK-3475 for Esophageal Squamous Cell Carcinoma (ACTS-29)
ClinicalTrials.gov study NCT02844075. IPD Sharing: NO. Countries: 1. Publications: 1.
Axitinib and Avelumab in Treating Patients With Recurrent or Metastatic Adenoid Cystic Carcinoma
ClinicalTrials.gov study NCT03990571. IPD Sharing: Not stated. Countries: 1. Publications: 1.
ONC201 in Recurrent/Refractory Metastatic Breast Cancer and Advanced Endometrial Carcinoma
ClinicalTrials.gov study NCT03394027. IPD Sharing: YES. Countries: 1. Publications: 4.
Screening Trial of Nivolumab With Image Guided, Stereotactic Body Radiotherapy (SBRT) Versus Nivolumab Alone in Patients With Metastatic Head and Neck Squamous Cell Carcinoma (HNSCC)
ClinicalTrials.gov study NCT02684253. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Study of Front Line Therapy With Nivolumab and Salvage Nivolumab + Ipilimumab in Patients With Advanced Renal Cell Carcinoma
ClinicalTrials.gov study NCT03117309. IPD Sharing: Not stated. Countries: 1. Publications: 2.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.